Last Chance to Submit Abstract for 2016 Advances in Inflammatory Bowel Diseases Conference

NEW YORK, Aug. 15, 2016 /PRNewswire-USNewswire/ -- Increase your prestige and gain exposure of your work by submitting an abstract for the 2016 Advances in Inflammatory Bowel Diseases (AIBD) Conference, the Crohn's & Colitis Foundation of America's (CCFA) Clinical Research Conference. Abstract submissions are being accepted until September 13, 2016 for AIBD. To submit an abstract, visit http://www.advancesinibd.com/abstracts.asp.

AIBD, taking place at the Walt Disney World Dolphin Hotel in Lake Buena Vista, Florida from December 8-10, is the only conference exclusively for gastroenterologists, pediatric specialists, clinical researchers, nurses, and other healthcare professionals with an interest in the treatment of pediatric and adult patients with inflammatory bowel diseases (IBD).The conference offers workshops, a four-track format designed for clinicians, researchers, allied health professionals, nurses and pediatric gastroenterologists.

Abstracts are being accepted in the following categories: Clinical, Pediatric, Basic Science or Nursing. Abstracts are subject to acceptance by the Scientific Abstract Review Committee. Abstracts selected for presentation will be published in Inflammatory Bowel Diseases journal and scheduled for oral or poster presentation. Acceptance notifications will be sent on October 17, 2016.

AIBD is endorsed by American College of Gastroenterology (ACG), American Gastroenterological Association (AGA), North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), and the British Society of Gastroenterology (BSG), and provides continuing medical education for physicians, nurses, and physician assistants.

About the Crohn's & Colitis Foundation of America
The Crohn's & Colitis Foundation of America (CCFA) is the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD). CCFA's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundation works to fulfill its mission by funding research; providing educational resources for patients and their families, medical professionals, and the public; and furnishing supportive services for those afflicted with IBD. For more information visit www.ccfa.org, call 888-694-8872, or email [email protected].

SOURCE Crohn's & Colitis Foundation of America

Related Links

http://www.ccfa.org